NAFLD/NASH: a ticking bomb not yet defused

Profil joined iPDM-GO

Artificial pancreas in type 2 diabetes

Digital Diabetes: better trials, better drugs, better care

Pramlintide as adjunct therapy for the treatment of type 1 diabetes

New strategies for the treatment of obesity and metabolic dysfunctions

Artificial Intelligence to Screen for Diabetic Retinopathy; The Times They Are A-Changin‘.

54th EASD Annual Meeting – Profil’s contributions to the scientific sessions

Profil explores opportunities for artificial pancreas in type 2 diabetes

Work stress is the new smoking